Real-world data on primary cutaneous lymphoproliferative disorders following SARS-CoV-2 vaccination: A multicentre experience from tertiary referral hospitals

J Eur Acad Dermatol Venereol. 2023 Apr;37(4):e451-e455. doi: 10.1111/jdv.18806. Epub 2022 Dec 19.
No abstract available

Publication types

  • Multicenter Study
  • Letter

MeSH terms

  • COVID-19 Vaccines* / adverse effects
  • COVID-19* / epidemiology
  • COVID-19* / prevention & control
  • Humans
  • SARS-CoV-2
  • Tertiary Care Centers
  • Vaccination

Substances

  • COVID-19 Vaccines